By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Accelrys today reported a 4 percent increase in revenues for its fourth fiscal quarter and a 2 percent increase for its full fiscal year.

The company said that its planned merger with scientific software firm Symyx, announced last month, has cleared the waiting period under Hart-Scott-Rodino antitrust regulations and is on track to close in early July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.